| Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies |
29 |
| Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) |
24 |
| From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome |
23 |
| Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different |
20 |
| The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies |
20 |
| Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management |
19 |
| Thyroid diseases and bone health |
18 |
| Diagnosis and treatment of lipodystrophy: a step-by-step approach |
18 |
| Safety of long-term antithyroid drug treatment? A systematic review |
17 |
| Polyglandular autoimmune syndromes |
17 |
| Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation |
16 |
| State of the art in osteoporosis risk assessment and treatment |
16 |
| Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
15 |
| Testosterone deficiency in non-cancer opioid-treated patients |
15 |
| Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy |
14 |
| Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients |
13 |
| The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) |
13 |
| Thyroid dysfunctions secondary to cancer immunotherapy |
12 |
| The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study |
12 |
| New perspectives on the definition and management of polycystic ovary syndrome |
12 |
| Vitamin D status and cardiovascular outcome |
12 |
| The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence |
11 |
| Transoral thyroidectomy: a viable surgical option with unprecedented complications-a case series |
11 |
| Impact of risk factors for gestational diabetes (GDM) on pregnancy outcomes in women with GDM |
10 |
| Expression of miR-217 and HIF-1 alpha/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats |
10 |
| Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4 |
9 |
| Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus |
9 |
| Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis |
9 |
| Antioxidant effects of beta-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) |
9 |
| Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) |
9 |
| Does a male polycystic ovarian syndrome equivalent exist? |
9 |
| Energy expenditure in the etiology of human obesity: spendthrift and thrifty metabolic phenotypes and energy-sensing mechanisms |
9 |
| Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study |
9 |
| A 2019 update on TSH-secreting pituitary adenomas |
9 |
| Effects of selenium and vitamin C on the serum level of antithyroid peroxidase antibody in patients with autoimmune thyroiditis |
9 |
| Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis |
9 |
| Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index |
9 |
| Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis |
8 |
| Lack of association between obesity and aggressiveness of differentiated thyroid cancer |
8 |
| Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults |
8 |
| The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology |
8 |
| Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1 |
8 |
| Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment? |
8 |
| The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes |
8 |
| Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study |
7 |
| Hormone of darkness and human reproductive process: direct regulatory role of melatonin in human corpus luteum |
7 |
| Classifying pain in transoral endoscopic thyroidectomy |
7 |
| NAFLD/NASH in patients with type 2 diabetes and related treatment options |
7 |
| Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis |
7 |
| Association of benign thyroid diseases with thyroid cancer risk: a meta-analysis of prospective observational studies |
7 |
